This inventor holds 1 USPTO granted patent. Top assignees: Isis Pharmaceuticals, Inc., Mcgill University. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,035 
1 out of 570 
Years Active: 2006
Title: Arlène Roland: Innovator in Oligonucleotide Technology
Introduction
Arlène Roland is a notable inventor based in Verdun, Canada. He has made significant contributions to the field of oligonucleotide technology, particularly through his innovative patent work. His expertise and dedication to research have led to advancements that benefit various scientific applications.
Latest Patents
Arlène Roland holds a patent for "Oligonucleotides having alkylphosphonate linkages and methods for their preparation." This invention provides alkylphosphonate dimers and oligonucleotides prepared from them. The patent also outlines novel methods for the preparation of these alkylphosphonate dimers, including techniques for achieving substantially diastereomerically pure alkylphosphonate dimers. He has 1 patent to his name.
Career Highlights
Throughout his career, Arlène has worked with prominent organizations, including Isis Pharmaceuticals, Inc. and McGill University. His roles in these institutions have allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Muthiah Manoharan and George Just. Their collaborative efforts have further advanced the research and development of oligonucleotide technologies.
Conclusion
Arlène Roland's contributions to oligonucleotide technology through his patent work and collaborations highlight his importance in the field. His innovative approaches continue to influence scientific research and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile